Improve the precise pathological diagnosis of intrahepatic cholangiocarcinoma: introduction to 2022 expert consensus on pathological diagnosis of intrahepatic cholangiocarcinoma in China

References

[1] Lamarca A,Utpatel K.Group: on behalf of the European Network for the Study of Cholangiocarcinoma (ENS-CCA)Liver metastases of intrahepatic cholangiocarcinoma: implications for an updated staging system.Hepatology2021;73:2311-25 PMCID:PMC8252018

[2] Committee of Expert Consensus on Pathological Diagnosis of Intrahepatic Cholangiocarcinoma (2022 version). [Expert consensus on pathological diagnosis of intrahepatic cholangiocarcinoma (2022 version)].Zhonghua Bing Li Xue Za Zhi2022;51:819-27

[3] Lin J,Yu H.Epidemiological characteristics of primary liver cancer in mainland china from 2003 to 2020: a representative multicenter study.Front Oncol2022;12:906778 PMCID:PMC9253580

[4] An L,Zhang S.Hepatocellular carcinoma and intrahepatic cholangiocarcinoma incidence between 2006 and 2015 in China: estimates based on data from 188 population-based cancer registries.Hepatobiliary Surg Nutr2023;12:45-55 PMCID:PMC9944524

[5] Nakanuma Y,Komuta M and Zen Y. Intrahepatic cholangiocarcinoma. In. WHO classification of tumours. Digestive system tumours. 5th edition. Lyon: IARC Press; 2019. p. 254-259.

[6] Zhou HB,Hu HP.Hepatitis B virus infection and intrahepatic cholangiocarcinoma.World J Gastroenterol2014;20:5721-9 PMCID:PMC4024782

[7] Lei Z,Si A.Antiviral therapy improves survival in patients with HBV infection and intrahepatic cholangiocarcinoma undergoing liver resection.J Hepatol2018;68:655-62

[8] Wang L,Zhao Y.Comprehensive molecular profiling of intrahepatic cholangiocarcinoma in the Chinese population and therapeutic experience.J Transl Med2020;18:273 PMCID:PMC7336472

[9] Yamada M,Sugiura T.Comparison of the clinicopathological features in small bile duct and bile ductular type intrahepatic cholangiocarcinoma.Anticancer Res2019;39:2121-7

[10] Hayashi A,Shibahara J.Distinct clinicopathologic and genetic features of 2 histologic subtypes of intrahepatic cholangiocarcinoma.Am J Surg Pathol2016;40:1021-30

[11] Vijgen S,Rubbia-Brandt L.Pathology of intrahepatic cholangiocarcinoma.Hepatobiliary Surg Nutr2017;6:22-34 PMCID:PMC5332210

[12] Nguyen Canh H,Yamamura M.Diversity in cell differentiation, histology, phenotype and vasculature of mass-forming intrahepatic cholangiocarcinomas.Histopathology2021;79:731-50

[13] Komuta M,Vander Borght S.Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin.Hepatology2008;47:1544-56

[14] Yamamoto M,Nishisaka T,Itamoto T.Synchronous double primary hepatic cancer consisting of hepatocellular carcinoma and cholangiolocellular carcinoma: a case report.J Med Case Rep2018;12:224 PMCID:PMC6098643

[15] Chen J,Qiu YD.Research advances on cholangiolocellular carcinoma.Chin J Hepatobiliary Surg2016;22:784-7

[16] Nakanuma Y,Ikeda H.Intrahepatic cholangiocarcinoma with predominant “ductal plate malformation” pattern: a new subtype.Am J Surg Pathol2012;36:1629-35

[17] Sigel CS,Zhou Y.Intrahepatic cholangiocarcinomas have histologically and immunophenotypically distinct small and large duct patterns.Am J Surg Pathol2018;42:1334-45 PMCID:PMC6657522

[18] Takahashi Y,Ishitobi H.Intrahepatic cholangiolocellular and cholangiocellular carcinoma - differences in the ¹⁸F-FDG PET/CT Findings.Intern Med2017;56:3027-31

[19] Sheng X,Ren GP.Liver Cancer Pathology Group of China (LCPGC)A standardized pathological proposal for evaluating microvascular invasion of hepatocellular carcinoma: a multicenter study by LCPGC.Hepatol Int2020;14:1034-47

[20] Cong WM,Chen J.Guideline CommitteePractice guidelines for the pathological diagnosis of primary liver cancer: 2015 update.World J Gastroenterol2016;22:9279-87 PMCID:PMC5107692